title: [Comparison of the efficiency of transluminal balloon angioplasty using EucaTAX and Cypher stents in patients with stable coronary heart disease].
abstract: OBJECTIVE
  To compare the long-term results of transluminal balloon coronary angioplasty in patients after implantation of drug-eluting coronary artery stents with permanent or biosoluble polymer coatings.
  
  
  METHODS
  This was a prospective, comparative, single-center trial. It enrolled patients having at least 70% stenosis who had undergone intracoronary Cypher (SES) or EucaTAX (EUPES) stent implantation.
  
  
  RESULTS
  The trial included 602 subjects, including 282 patients with a placed EUPES stent and 320 patients with an implanted SES stent. Two years later, there was a higher rate of repeat revascularization in the EUPES group than in the SES group (16.3% versus 6.25%; p = 0.0001) and that of great unfavorable events in these groups (18.4% versus 7.8%; p = 0.001). According to the angiographic parameters of in-stent restenosis, the rate of repeat target-segment revascularization was significantly higher in the EUPES group than that in the EucaTAX group while stenting coronary arteries less than 3 mm in diameter, using stents more than 18 mm in length, as well as in residual stenosis of more than 12% as compared to the SES group.
  
  
  CONCLUSIONS
  In the SES group, the clinical outcomes were better than those in the EUPES group during 2-year follow-up; the rate of target lesion revascularization was significantly higher in the EUPES group.
authors.forename: R O
authors.initials: RO
authors.lastname: Shirokov
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Shuvalova
authors.forename: A N
authors.initials: AN
authors.lastname: Samko
authors.forename: I V
authors.initials: IV
authors.lastname: Levitskiĭ
authors.forename: A I
authors.initials: AI
authors.lastname: Kaminnyĭ
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data; D002317:Cardiovascular Agents / Q000627:therapeutic use; D057186:Comparative Effectiveness Research; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000401:mortality / Q000503:physiopathology / Q000601:surgery; D003331:Coronary Vessels / Q000473:pathology / Q000503:physiopathology; D054855:Drug-Eluting Stents / Q000009:adverse effects / Q000592:standards / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D062072:Patient Acuity; D011474:Prosthesis Design; D012086:Reoperation / Q000706:statistics & numerical data; D016019:Survival Analysis; D014654:Vascular Patency
chemical_list: D002317:Cardiovascular Agents